CAS RN: 65501-24-8

EDTA tripotassium salt (EDTA-3K·2H2O)

Product Availability

Choose a grade to view its available package options.

5 package records5 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20250925 100g In stock Inquiry
Batchno.20250722 2.5kg In stock Inquiry
Batchno.20260207 25g In stock Inquiry
Batchno.20250315 500g In stock Inquiry
Batchno.20251022 50g In stock Inquiry
  • Product code: SSC-175152
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 500g
  • Available purity: >97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 65501-24-8
Pack Size Recorded Purity Available Qty Ship From Inquiry
500g >97% 0 Out of Stock Shanghai Inquiry

65501-24-8 / tripotassium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate;dihydrate

Standard CAS: 65501-24-8 Multi CAS: Yes

Basic Information

CAS
65501-24-8
Multi CAS
Yes
Molecular Formula
C10H17K3N2O10
Molecular Weight
442.540000
Exact Mass
441.979439
InChI
InChI=1S/C10H16N2O8.3K.2H2O/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;;2*1H2/q;3*+1;;/p-3
InChIKey
MAPFUJCWRWFQIY-UHFFFAOYSA-K

Computed Properties

Structural Parameters

Heavy atom count
25
Fraction Csp3
0.6
Rotatable bonds
11
H-bond acceptors
9
H-bond donors
1
Molar refractivity
62.76
TPSA
227.17

LogP / Solubility

WLOGP
-16.71
MLOGP
-14.68
XLogP3
-16.71
Consensus LogP
-16.03
Log S (ESOL)
8.67
Class (ESOL)
Highly soluble
Log S (Ali)
8.88
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
10.02
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-17.29

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us